Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Oncologist
|
May 25, 2006
Intravascular lymphoma: the oncologist's "great imitator"
Dan Zuckerman, Rania Seliem, Ephraim Hochberg
Journal of Clinical Epidemiology
|
March 10, 2007
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
Sebastian Schneeweiss, Ari Robicsek, Richard Scranton, et al.
The Oncologist
|
May 25, 2006
Teams: communication in multidisciplinary care
Richard T Penson, Helena Kyriakou, Dan Zuckerman, et al.
Journal of Oncology Practice
|
December 29, 2016
Establishing a Core Set of Performance Measures to Improve Value in Cancer Care: ASCO Consensus Conference Recommendation Report
Michael Neuss, Gabrielle Rocque, Dan Zuckerman, et al.
JAMA
|
April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
Kimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Cancers
|
November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial
Justin C Brown, Michael H Rosenthal, Chao Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Sara M Tolaney, Nabihah Tayob, Chau Dang, et al.
NPJ Breast Cancer
|
February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Oncologist
|
May 25, 2006
Intravascular lymphoma: the oncologist's "great imitator"
Dan Zuckerman, Rania Seliem, Ephraim Hochberg
Journal of Clinical Epidemiology
|
March 10, 2007
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
Sebastian Schneeweiss, Ari Robicsek, Richard Scranton, et al.
The Oncologist
|
May 25, 2006
Teams: communication in multidisciplinary care
Richard T Penson, Helena Kyriakou, Dan Zuckerman, et al.
Journal of Oncology Practice
|
December 29, 2016
Establishing a Core Set of Performance Measures to Improve Value in Cancer Care: ASCO Consensus Conference Recommendation Report
Michael Neuss, Gabrielle Rocque, Dan Zuckerman, et al.
JAMA
|
April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial
Kimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Cancers
|
November 25, 2020
Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial
Justin C Brown, Michael H Rosenthal, Chao Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Sara M Tolaney, Nabihah Tayob, Chau Dang, et al.
NPJ Breast Cancer
|
February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.
Page
of 1